Sökning: "leukemia inhibitory factor"
Visar resultat 11 - 15 av 20 avhandlingar innehållade orden leukemia inhibitory factor.
11. Molecular and functional studies on human embryo implantation : targets for infertility and fertility regulation
Sammanfattning : Background: An estimated one in four couples globally suffers from infertility or fertility related issues and rate of global infertility is about 10-15%. Despite the best optimization of assisted reproductive technique the pregnancy rate is not more than 30%. LÄS MER
12. Levonorgestrel emergency contraception : effects on endometrial development and embryo implantation
Sammanfattning : Background: The dialog between the developing embryo and receptive endometrium is under the control of ovarian steroids and numerous biomolecules, some of which have been suggested as markers of endometrial receptivity. Unintended pregnancies are common. The standard treatment with levonorgestrel (LNG, 1. LÄS MER
13. Immunoregulation by mononuclear phagocytes. Mechanisms and clinical implications
Sammanfattning : The cytotoxic effector lymphocytes of the immune system, the natural killer (NK) cells and the CD8+ T lymphocytes (CTL), have been ascribed a pivotal role in defense against malignancy. However, the function of these cells is frequently compromised, in particular at sites of malignant cell expansion. LÄS MER
14. Identification and characterization of novel genetic and epigenetic factors required for normal and malignant hematopoiesis
Sammanfattning : Acute myeloid leukemia (AML) is a type of blood cancer, characterized by clonal expansion and loss of differentiation ability of myeloid progenitor cells leading to abnormal accumulation of immature myeloid cells (myeloblasts) in the bone marrow and peripheral blood. This thesis (study I to IV) focused on the identification and characterization of genes which are required for AML growth. LÄS MER
15. Concepts in DNA immunization overcoming viral diversity and enhancing plasmid immunogenicity
Sammanfattning : On April 23, 1984, the prominent scientist Robert Gallo held a historical press conference at the Department of Health and Human Services, Washington D.C., USA. He announced that his laboratory at the National Institutes of Health had over the last months isolated a retrovirus named Human T-cell Leukemia Virus type III (HTLV-III). LÄS MER